Therefore, [18F]2, through the PET imaging of MC-I activity, has exhibited its capability to evaluate MC-I dysfunction in AD mouse models, representing a promising tool for studying the progression and potential therapeutic interventions for AD. The gene discussed is MCIDAS; the disease is Alzheimer disease.